Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dawn M. Carlson
Results of a Phase I, Open-Label, Randomized, Crossover Study Evaluating the Effects of Linifanib on QTc Intervals in Patients With Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies
Clinical Therapeutics
Pharmacology
A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Phase I, Open-Label, Randomized, Crossover Study in Healthy Subjects to Evaluate the Bioavailability Of, and the Food Effect On, a Pomalidomide Oral Liquid Suspension
Clinical Pharmacology: Advances and Applications
Pharmacology
An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Patients With Advanced Solid Tumors
European Journal of Drug Metabolism and Pharmacokinetics
Pharmacology
A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Randomised, Open-Label, Crossover Study of the Dopamine Agonist, Pramipexole, in Patients With Sleep Bruxism
Journal of Sleep Research
Medicine
Behavioral Neuroscience
Cognitive Neuroscience
Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
A Phase I Study of BMS-690514 in Japanese Patients With Advanced or Metastatic Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Dose-Escalation Study of Intravenous Panobinostat in Patients With Lymphoma and Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
